Gilead posts results of Phase 3 ARTISTRY-2 study of BIC/LEN versus B/F/TAF
Results for the Phase 3 ARTISTRY-2 study were first posted on ClinicalTrials.gov on November 5, 2026. The study enrolled 577 participants and completed primary data collection on October 27, 2025.
Primary source
ClinicalTrials.gov results record, November 5, 2026
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
Read the source: Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation